India's Gennova Biopharma developing Omicron-specific Covid vaccine: Sources

[email protected]21 Feb, 2022News

Gennova Biopharmaceuticals, a Pune-based company which is making India's first mRNA vaccine, has submitted phase-2 trial data of its mRNA Covid-19 vaccine. The Drugs Controller General of India's (DCGI) Subject Expert Committee (SEC) will review the data soon. Sources said the company has also developed an Omicron-specific vaccine, which will be tested on humans for efficacy & immunogenicity soon. During his speech at the 76th United Nations General Assembly (UNGA), Prime Minister Narendra Modi had earlier stated that India?s first mRNA vaccine was in the final stages.